Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566280 · ClinicalTrials.gov registry record · NA
Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00566280: Completed NA study, sponsored by Mayo Clinic.
NCT00566280 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00566280, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate molecular breast imaging in the workup of patients with a history of bloody nipple discharge, not reproducible in the office who have a negative clinical breast examination, and a negative diagnostic mammogram and breast ultrasound.
Interventions
- PROCEDURE Molecular Breast Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566280
The ClinicalTrials.gov registry entry for NCT00566280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular Breast Imaging is the first listed.
NCT00566280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00566280 about?
NCT00566280 is a clinical study titled "Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge". The purpose of this study is to evaluate molecular breast imaging in the workup of patients with a history of bloody nipple discharge, not reproducible in the office who have a negative clinical breast examination, and a negative diagnostic mammogram and breast ultrasound.
What is the current status of trial NCT00566280?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2006-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00566280?
The interventions under investigation include: Molecular Breast Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00566280?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.